123 related articles for article (PubMed ID: 10874450)
41. A 40-year-old man with neutropenic fever and lobar consolidation.
Holley A; Mayes D; Browning R
Chest; 2008 Mar; 133(3):816-9. PubMed ID: 18321912
[No Abstract] [Full Text] [Related]
42. Significance of C-reactive protein during febrile neutropenia in pediatric malignancies.
Avabratha KS; Rau AT; Venkataravanamma P; Rau A
Indian Pediatr; 2009 Sep; 46(9):797-9. PubMed ID: 19430077
[TBL] [Abstract][Full Text] [Related]
43. Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients.
Oude Nijhuis CSM; Vellenga E; Daenen SMGJ; van der Graaf WTA; Gietema JA; Groen HJM; Kamps WA; de Bont ESJM
Intensive Care Med; 2003 Dec; 29(12):2157-2161. PubMed ID: 14569424
[TBL] [Abstract][Full Text] [Related]
44. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.
Engel A; Mack E; Kern P; Kern WV
Infection; 1998; 26(4):213-21. PubMed ID: 9717678
[TBL] [Abstract][Full Text] [Related]
45. Identifying risk factors for refractory febrile neutropenia in patients with lung cancer.
Fujita M; Tokunaga S; Ikegame S; Harada E; Matsumoto T; Uchino J; Watanabe K; Nakanishi Y
J Infect Chemother; 2012 Feb; 18(1):53-8. PubMed ID: 21773751
[TBL] [Abstract][Full Text] [Related]
46. Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
Paganini HR; Sarkis CM; De Martino MG; Zubizarreta PA; Casimir L; Fernandez C; Armada AA; Rodriguez-Brieshcke MT; Debbag R
Cancer; 2000 Jun; 88(12):2848-52. PubMed ID: 10870071
[TBL] [Abstract][Full Text] [Related]
47. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation.
Ortega M; Rovira M; Filella X; Almela M; Puig de la Bellacasa J; Carreras E; Mensa J
Br J Haematol; 2004 Aug; 126(3):372-6. PubMed ID: 15257709
[TBL] [Abstract][Full Text] [Related]
48. Predicting the complicated neutropenic fever in the emergency department.
Moon JM; Chun BJ
Emerg Med J; 2009 Nov; 26(11):802-6. PubMed ID: 19850806
[TBL] [Abstract][Full Text] [Related]
49. Serum amino-terminal pro-brain natriuretic peptide in hematological patients with neutropenic fever: a prospective comparison with C-reactive protein.
Hämäläinen S; Juutilainen A; Kuittinen T; Nousiainen T; Matinlauri I; Pulkki K; Koivula I; Jantunen E
Leuk Lymphoma; 2010 Jun; 51(6):1040-6. PubMed ID: 20470220
[TBL] [Abstract][Full Text] [Related]
50. Serum derivative of reactive oxygen metabolites (d-ROMs) in pediatric hemato-oncological patients with neutropenic fever.
Nishikawa T; Okamoto Y; Kodama Y; Tanabe T; Shinkoda Y; Kawano Y
Pediatr Blood Cancer; 2010 Jul; 55(1):91-4. PubMed ID: 20486174
[TBL] [Abstract][Full Text] [Related]
51. Monitoring of endotoxin, interleukin-6 and C-reactive protein serum concentrations in neutropenic patients with fever.
Engervall P; Granström M; Andersson B; Björkholm M
Eur J Haematol; 1995 Apr; 54(4):226-34. PubMed ID: 7789467
[TBL] [Abstract][Full Text] [Related]
52. Differences in characteristics between first and breakthrough neutropenic fever after chemotherapy in patients with hematologic disease.
Nam EY; Song KH; Kim NH; Kim M; Kim CJ; Lee JO; Choe PG; Park WB; Bang JH; Kim ES; Park SW; Kim HB; Bang SM; Kim NJ; Oh MD
Int J Infect Dis; 2016 Mar; 44():4-7. PubMed ID: 26780270
[TBL] [Abstract][Full Text] [Related]
53. Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults.
Bernard L; Ferrière F; Casassus P; Malas F; Lévêque S; Guillevin L; Lortholary O
Clin Infect Dis; 1998 Oct; 27(4):914-5. PubMed ID: 9798066
[No Abstract] [Full Text] [Related]
54. Significance of interleukin-6 (IL-6) and C-reactive protein (CRP) in children and young adults with febrile neutropenia during chemotherapy for cancer: a prospective study.
Chaudhary N; Kosaraju K; Bhat K; Bairy I; Borker A
J Pediatr Hematol Oncol; 2012 Nov; 34(8):617-23. PubMed ID: 22983415
[TBL] [Abstract][Full Text] [Related]
55. [Utility of procalcitonin for the diagnosis and the follow-up of infections in febrile neutropenic patients].
Robinson JO; Calandra T; Marchetti O
Rev Med Suisse; 2005 Mar; 1(13):878-82, 885-6. PubMed ID: 15895930
[TBL] [Abstract][Full Text] [Related]
56. Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: Causes and consequences.
Hämäläinen S; Kuittinen T; Matinlauri I; Nousiainen T; Koivula I; Jantunen E
Leuk Lymphoma; 2008 Mar; 49(3):495-501. PubMed ID: 18297526
[TBL] [Abstract][Full Text] [Related]
57. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia.
de Bont ES; Vellenga E; Swaanenburg JC; Fidler V; Visser-van Brummen PJ; Kamps WA
Br J Haematol; 1999 Nov; 107(2):375-80. PubMed ID: 10583227
[TBL] [Abstract][Full Text] [Related]
58. A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia.
Manian FA
Clin Infect Dis; 1995 Jul; 21(1):114-21. PubMed ID: 7578719
[TBL] [Abstract][Full Text] [Related]
59. Clinical and laboratory parameter dynamics as markers of blood stream infections in pediatric oncology patients with fever and neutropenia.
Hazan G; Ben-Shimol S; Fruchtman Y; Abu-Quider A; Kapelushnik J; Moser A; Falup-Pecurariu O; Greenberg D
J Pediatr Hematol Oncol; 2014 Jul; 36(5):e275-9. PubMed ID: 24276046
[TBL] [Abstract][Full Text] [Related]
60. Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia.
Heney D; Lewis IJ; Evans SW; Banks R; Bailey CC; Whicher JT
J Infect Dis; 1992 May; 165(5):886-90. PubMed ID: 1569338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
